ARTL Artelo Biosciences Inc.: שווי החברה בספרים

The Artelo Biosciences (ARTL) price chart demonstrates the asset's dynamics, with a value of 0.01. The business relies on strict control of cannabinoid supplies and production diversification to protect margins. The current development vector is linked to trials of unique small molecules, which is intended to limit financial risks. Artelo Biosciences is implementing lipid modulation methods, creating effective supportive therapy for oncology and pain syndromes.

The specifics of developing cannabinoid receptor modulators with a dependence on grants make the financial stability of Artelo Biosciences (ARTL) critically important. This indicator reflects the difference between all assets and liabilities, measuring the actual net equity available to cover binary pipeline risks. By analyzing the equity level based on book value on GURU.Markets, an investor determines the business's actual margin of safety under negative scenarios.